|
KK-LC-1 TCR-T cells Clinical Trials
1 actively recruiting trial across 1 location
No change since May 2026
Also known as: Adoptive cell transfer, CAR-T, KK-LC-1 TCR, TCR, TIL
Pipeline
Phase 1: 1
Top Sponsors
- Christian Hinrichs1
Indications
- Gastric Cancer1
- Cervical Cancer1
- Lung Cancer1
- Breast Cancer1
- Cancer1
New Brunswick, New Jersey1 trial
KK-LC-1 TCR-T Cell Therapy for Gastric, Breast, Cervical, and Lung Cancer
Rutgers Cancer Institute of New Jersey
Phase 1
Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.
This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.